Video

Potential Molecular Markers in Liver Cancer

Anuradha S. Budhu, PhD, discusses using molecular features as predictive markers in liver cancer.

Anuradha S. Budhu, PhD, senior associate scientist, Laboratory of Human Carcinogenesis, program manager, Liver Cancer Program, Center for Cancer Research, National Cancer Institute, discusses using molecular features as predictive markers in liver cancer.

Genes are an important molecular feature that can shed light on individual biology, says Budhu. As such, investigators compare normally expressed genes with dysregulated or overexpressed genes to gain insight on cancer biology.

Other potential markers include microRNAs and downstream affecters of gene signaling such as metabolites and proteins, says Budhu.

By measuring the abundance of these features, investigators are aiming to understand tumor biology. These markers may help to identify liver cancer in patients, predict the aggressiveness of the disease, and determine which patients will benefit the most from treatment.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center